Literature DB >> 19356672

An update on the regulatory status of PDT photosensitizers in China.

Zheng Huang1.   

Abstract

Numerous photosensitizers have been developed and evaluated in China. HiPorfin, a hematoporphyrin derivative (HpD) received the first regulatory approval in the early 2000s. Aila, a topical formulation containing predrug 5-aminolevulinic acid, received the regulatory approval in 2007. Recently, new drug applications have been filed for several hematoporphyrin derivatives and a zinc phthalocyanine (ZnPc) derivative. This short report will summarize the current regulatory status of Chinese photosensitizers developed for photodynamic therapy (PDT).

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19356672     DOI： 10.1016/j.pdpdt.2009.01.005

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN： 1572-1000            Impact factor:   3.631


  9 in total

1.  Pentalysine beta-carbonylphthalocyanine zinc: an effective tumor-targeting photosensitizer for photodynamic therapy.

Authors:  Zhuo Chen; Shanyong Zhou; Jincan Chen; Yicai Deng; Zhipu Luo; Hongwei Chen; Michael R Hamblin; Mingdong Huang
Journal:  ChemMedChem       Date:  2010-06-07       Impact factor: 3.466

Review 2.  A promising anticancer drug: a photosensitizer based on the porphyrin skeleton.

Authors:  Qizhi Zhang; Jun He; Wenmei Yu; Yanchun Li; Zhenhua Liu; Binning Zhou; Yunmei Liu
Journal:  RSC Med Chem       Date:  2020-02-25

Review 3.  Shining light on nanotechnology to help repair and regeneration.

Authors:  Asheesh Gupta; Pinar Avci; Magesh Sadasivam; Rakkiyappan Chandran; Nivaldo Parizotto; Daniela Vecchio; Wanessa C M A de Melo; Tianhong Dai; Long Y Chiang; Michael R Hamblin
Journal:  Biotechnol Adv       Date:  2012-08-21       Impact factor: 14.227

4.  Synthesis of sialic acid conjugates of the clinical near-infrared dye as next-generation theranostics for cancer phototherapy.

Authors:  Huiling Dong; Yanan Gao; Xuefei Huang; Xuanjun Wu
Journal:  J Mater Chem B       Date:  2022-02-09       Impact factor: 7.571

5.  Dark and Photoinduced Cytotoxic Activity of the New Chlorophyll-a Derivatives with Oligoethylene Glycol Substituents on the Periphery of Their Macrocycles.

Authors:  Yana I Pylina; Dmitry M Shadrin; Oksana G Shevchenko; Olga M Startseva; Igor O Velegzhaninov; Dmitry V Belykh; Ilya O Velegzhaninov
Journal:  Int J Mol Sci       Date:  2017-01-05       Impact factor: 5.923

6.  Clinical Efficacy of HiPorfin Photodynamic Therapy for Advanced Obstructive Esophageal Cancer.

Authors:  Ruifang Zeng; Chen Liu; Libo Li; Xiaojun Cai; Run Chen; Zhiwen Li
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

Review 7.  Progress of Phototherapy Applications in the Treatment of Bone Cancer.

Authors:  Jiachen Sun; Fei Xing; Joy Braun; Frank Traub; Pol Maria Rommens; Zhou Xiang; Ulrike Ritz
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

8.  The Efficacy of Hematoporphyrin Monomethyl Ether Photodynamic Therapy in Adult Patients with Port-Wine Stains: A Retrospective Study.

Authors:  Xin-Yu Zhang; Najwa Al-Odaini; Run-Ge Fan; Hong-di Xiong; Jia-Can Huang; Hong-Mei Dai; Yan-Hua Zhou; Xiu-Yin Huang; Si-Jian Wen
Journal:  Dermatol Ther (Heidelb)       Date:  2022-03-04

Review 9.  Clinical development and potential of photothermal and photodynamic therapies for cancer.

Authors:  Xingshu Li; Jonathan F Lovell; Juyoung Yoon; Xiaoyuan Chen
Journal:  Nat Rev Clin Oncol       Date:  2020-07-22       Impact factor: 66.675
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.